The shockwave therapy market would grow at a CAGR of 11.12% over the predicted time frame. The market is expected to increase in value from US$ 1.33 Bn in 2022 to US$ 3.1 Bn in 2030.
The on shockwave therapy Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/1861
Report Scope of the Shock Wave Therapy Market
Report Coverage | Details |
Market Size in 2022 | USD 1.33 Billion |
Market Size by 2030 | USD 3.1 Billion |
Growth Rate from 2022 to 2030 | CAGR of 11.12% |
North America Market Share in 2021 | 46% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Technique, Product, Diseases, Application, End User, Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Shockwave therapy Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Shockwave therapy market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Shockwave therapy market are included as given below:
Shockwave therapy Market Key Players
- Dornier MedTech GmbH
- Zimmer MedizinSysteme GmbH
- Medtrue Enterprise Co. Ltd.
- MS Electro Medical Systems S.A.
- BTL Corporate
- Lumenis Ltd.
- Edaptms TMS
- Boston Scientific Corporation
- C.R. Bard Inc.
- Cook Group Inc.
- Olympus Corporation
Market Segments
By Technique
- Radial Shock Waves
- Electromagnetic Shock Waves
- Electrohydraulic Shock Waves
- Piezoelectric Shock Waves
- Others
By Product
- Fixed Shockwave Therapy Devices
- Mobile Shockwave Therapy Devices
By Diseases
- Medial Tibial Stress Syndrome
- Upper & Lower Extremity Tendinopathies
- Long Bone Fracture
- Plantar Fasciopathy
- Avasive Necrosis
- Others
By Application
- Urology
- Cardiology
- Orthopedic
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Laboratories
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global shockwave therapy market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the shockwave therapy market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Shock Wave Therapy Market
5.1. COVID-19 Landscape: Shock Wave Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Shock Wave Therapy Market, By Technique
8.1. Shock Wave Therapy Market, by Technique, 2022-2030
8.1.1. Radial Shock Waves
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Electromagnetic Shock Waves
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Electrohydraulic Shock Waves
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Piezoelectric Shock Waves
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Shock Wave Therapy Market, By Product
9.1. Shock Wave Therapy Market, by Product, 2022-2030
9.1.1. Fixed Shockwave Therapy Devices
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Mobile Shockwave Therapy Devices
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Shock Wave Therapy Market, By Diseases
10.1. Shock Wave Therapy Market, by Diseases, 2022-2030
10.1.1. Medial Tibial Stress Syndrome
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Upper & Lower Extremity Tendinopathies
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Long Bone Fracture
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Plantar Fasciopathy
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Avasive Necrosis
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Shock Wave Therapy Market, By Application
11.1. Shock Wave Therapy Market, by Application, 2022-2030
11.1.1. Urology
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cardiology
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Orthopedic
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Shock Wave Therapy Market, By End User
12.1. Shock Wave Therapy Market, by End User, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Clinics
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Diagnostic Laboratories
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Shock Wave Therapy Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technique (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technique (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7. Market Revenue and Forecast, by End User (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Technique (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technique (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technique (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technique (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technique (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technique (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technique (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technique (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technique (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technique (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technique (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technique (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technique (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technique (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technique (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technique (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technique (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technique (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technique (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Diseases (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. Dornier MedTech GmbH
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Zimmer MedizinSysteme GmbH
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Medtrue Enterprise Co. Ltd.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MS Electro Medical Systems S.A.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. BTL Corporate
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Lumenis Ltd
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Edaptms TMS
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Boston Scientific Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. C.R. Bard Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Cook Group Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments